Purple Biotech Statistics Share Statistics Purple Biotech has 13.24K
shares outstanding. The number of shares has increased by 6.2%
in one year.
Shares Outstanding 13.24K Shares Change (YoY) 6.2% Shares Change (QoQ) 4.95% Owned by Institutions (%) 0% Shares Floating 13.53K Failed to Deliver (FTD) Shares 13,605 FTD / Avg. Volume 1.56%
Short Selling Information The latest short interest is 103.15K, so 3.9% of the outstanding
shares have been sold short.
Short Interest 103.15K Short % of Shares Out 3.9% Short % of Float 4% Short Ratio (days to cover) 4.76
Valuation Ratios The PE ratio is -1.67 and the forward
PE ratio is -1.19.
Purple Biotech's PEG ratio is
0.
PE Ratio -1.67 Forward PE -1.19 PS Ratio 0 Forward PS 0 PB Ratio 0.37 P/FCF Ratio -0.84 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Purple Biotech.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.23,
with a Debt / Equity ratio of 0.01.
Current Ratio 2.23 Quick Ratio 2.23 Debt / Equity 0.01 Debt / EBITDA -0.03 Debt / FCF -0.01 Interest Coverage -24.62
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-804.44K Employee Count 9 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -92.9% in the
last 52 weeks. The beta is -0.51, so Purple Biotech's
price volatility has been lower than the market average.
Beta -0.51 52-Week Price Change -92.9% 50-Day Moving Average 2.24 200-Day Moving Average 2.84 Relative Strength Index (RSI) 12.2 Average Volume (20 Days) 871,112
Income Statement
Revenue n/a Gross Profit -186K Operating Income -11.01M Net Income -7.24M EBITDA -7.05M EBIT -7.24M Earnings Per Share (EPS) -4.42
Full Income Statement Balance Sheet The company has 7.4M in cash and 183K in
debt, giving a net cash position of 7.22M.
Cash & Cash Equivalents 7.4M Total Debt 183K Net Cash 7.22M Retained Earnings -144.69M Total Assets 34.38M Working Capital 4.12M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -14.37M
and capital expenditures 0, giving a free cash flow of -14.37M.
Operating Cash Flow -14.37M Capital Expenditures n/a Free Cash Flow -14.37M FCF Per Share -5.56
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields PPBT does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for PPBT is $33,
which is 5056.2% higher than the current price. The consensus rating is "Buy".
Price Target $33 Price Target Difference 5056.2% Analyst Consensus Buy Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Sep 17, 2024. It was a
backward
split with a ratio of 1:20.
Last Split Date Sep 17, 2024 Split Type backward Split Ratio 1:20
Scores Altman Z-Score -6.05 Piotroski F-Score 2
